Seattle Westlake Provenge Rally

A rally in support of Dendreon Corp.'s Provenge prostate cancer drug on May 30, with protests in nine U.S. cities.

A nonprofit group called CareToLive is sponsoring the protests in response to the Food and Drug Administration's May 2007 decision to stall approval of Provenge by requesting additional clinical data, although a few months earlier, an FDA committee had made a favorable recommendation on the drug.

This story is inappropriate and should be flagged for moderation. Please choose from one of the following options:

You have indicated this comment should be removed.

Close

The comment has been submitted for review. Thank you .

MIke says ... on Thursday, Jun 5 at 6:57 AM

Since the FDA issued the Approvable Letter and delayed patient access to Provenge, 32,536 men have now suffered needlessly premature and painful deaths from prostate cancer as a result of the lack of availability of Provenge.

Mike Jones says ... on Tuesday, Jun 3 at 9:27 AM

This drug is not on the market due to two of the Doctors on the panel being paid off. see link below http://caretolive.com/

Jason says ... on Tuesday, Jun 3 at 9:08 AM

We are seeking access to the immunotherapy Provenge for end stage prostate cancer. Please visit www.CareToLive.com for more information on the FDA's delay of Provenge. 1 in 6 Men Get Prostate Cancer 75 American Men Die From It Every Day

Add a comment

Name:

Comment: 250 Characters Left

KOMO News and its affiliated companies are not responsible for the content of comments posted or for anything arising out of use of the above comments or other interaction among the users. We reserve the right to screen, refuse to post, remove or edit user-generated content at any time and for any or no reason in our absolute and sole discretion without prior notice, although we have no duty to do so or to monitor any Public Forum.